Navigation Links
Gentamicin in Medical News

Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma

ASHBURN, Va., Sept. 6 /PRNewswire/ -- Innocoll, Inc. announced that it has agreed the sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European sales and marketing infrastructure to EUSA Pharma Inc., a transatlantic specialty pharmaceutical company focused on oncology, pain control and c...

BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units

...n standard infection control measures. Over a 10-month period, BUSM researchers conducted studies for colonization and bloodstream infections with gentamicin or third generation cephalosporin-resistant GNR among all NICU infants weekly and then on the day of discharge. Researchers found a total of 1,997 res...

Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?'

... Michigan to spray the state's apple orchards with gentamicin risks undermining the value of this important anti...he state of Michigan "emergency" permission to use gentamicin to fight a tree disease called fire blight. "At...pples," said IDSA President Donald Poretz, MD. gentamicin is a crucial antibiotic used to treat dangerous ga...

AlphaRx Signs Cooperative Research and Development Agreement with US Army

...ed mainly in biological weapons that pose a risk to national security. The MTA covers several "nanobiotics" including Ciprofloxacin, Doxycycline and gentamicin developed by AlphaRx. These are the usual antibiotics used to treat patients in a bioterrorism event. However, they all show limited efficacy clinical...

Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology

...nology forms the basis of Innocoll's lead product, gentamicin Surgical Implant, a biodegradable leave-behind imp...ost-operative pain and a topically-applied CollaRx gentamicin Sponge for the treatment and prevention of diabeti...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...

Bacteriophages may Boost the Effectiveness of Antibiotics

...spital-acquired infections. Experiments in mice revealed that 75% of those infected with a lethal dose of Pseudomonas survived if the antibiotic gentamicin was administered in the presence of bacteriophages. None survived without the phages (Microb. Drug Resist., 2006, 12 (3), 164). The bacteriophag...

Red Wine May Reduce The Risk Of Age Related Deafness

...atients' ears caused by the antibiotic gentamicin. gentamicin they explained is often used to treat severe, acut...ss had affected just 3% of patients who were given gentamicin plus aspirin for acute ear infections compared with 13% treated with gentamicin plus a placebo. Jochen Schacht while present...
Gentamicin in Medical Technology

Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients

ASHBURN, Va., March 19 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the second of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R)...

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

ASHBURN, Va., March 16 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) ...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections

ASHBURN, Va., April 30 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the treatmen...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers

ASHBURN, Va., April 17 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the second of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the treatm...

Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections

ASHBURN, Va., Feb. 19 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the second of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the p...

Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients

ASHBURN, Va., Jan. 2 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the first of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the pre...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers

ASHBURN, Va., Dec. 18 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the first of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the t...

Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...ghts with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

...thetic patch which recently received Europe-wide approval. EUSA also has several products in late-stage development, notably Collatamp(R) G topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx(R) bupivacaine implant* for local post-surgical pain...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain

... pharmaceutical products and medical devices using its proprietary collagen-based technologies, CollaRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin SURGICAL IMPLANT, for the treatment and prevention of surgical site infections, is approved for sale in 49 countries in Europe, Latin America, Middle ...
Gentamicin in Medical Products

Depuy 1 Gentamicin Bone Cement

Description: DePuy 1 Gentamicin Bone Cement, a high viscosity antibiotic bone cement, clinically proven in the international market for over a decade, eliminates the inconvenience of mixing an antibiotic into cement. The premixed powder helps to prevent inconsistency in cement-handling characteristics. DePuy 1 ...
Company:DePuy Orthopaedics, Inc.

Gibco Gentamicin Reagent Solution (50 mg/ml) liquid

Description: Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....
Company:Invitrogen

Gibco Gentamicin Reagent Solution (50 mg/ml), liquid

Description: Contains 50 mg/ml gentamicin sulfate in distilled water....
Company:Invitrogen

Gibco Gentamicin Reagent Solution (10 mg/ml) liquid

Description: Gentamicin Reagent Solution (10 mg/ml) liquid...
Company:Invitrogen

Palacos® G Bone Cement with Gentamicin

Description: For over 35 years, Palacos® Bone Cement has clinically proven itself as the gold standard in cemented arthroplasty. Palacos® is now available with the addition of gentamicin, providing an antibiotic loaded bone cement cleared for use in the second stage of a two-stage revision after infecti...
Company:Biomet Orthopedics, Inc

CEMEX Genta

Description:... Bone cement with gentamicin 2.5%....
Company:Exactech, Inc.

Gentamicin

Description:... gentamicin is an aminoglycosidic antibiotic that inhibits bacterial growth by inhibiting protein synthesis. gentamicin is used for prevention and elimination of bacterial contaminants in cell cu...
Company:Roche Applied Science

GENTAFIX 3

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

CEMFIX 3

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

GENTAFIX 1

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

More>>

Gentamicin in Biological News

Milk may help bacteria survive against low levels of antibiotics

...t milk may also protect bacteria against low concentrations of antibiotics in the presence of milk, three of the five antibiotics tested, penicillin, gentamicin and sulphamethoxazole combined with trimethoprim, were less effective against Staphylococcus when compared with the same experiment performed in the a...

Poultry workers at increased risk of carrying antibiotic-resistant E. coli

...or resistance to the antimicrobials ampicillin, ciprofloxacin, ceftriazone, gentamicin and tetracycline. Findings showed that poultry workers had 32 times greater...nt antimicrobial drugs are approved for use in U.S. poultry production with gentamicin reported to be the most widely used. ...

Clues to gene expression in cystic fibrosis will guide research

...rare genetic stop mutation responded positively to gentamicin treatment. Aleksander Edelman and Isabelle Serme...al French institutions studying how the antibiotic gentamicin affected CF patients with a stop mutation. The tea...nly in inhabitants of Reunion island, responded to gentamicin treatment. Cystic fibrosis is caused by mutat...

New approach could lower antibiotic requirements by 50 times

...hospital-acquired infections. Experiments in mice revealed that 75% of those infected with a lethal dose of Pseudomonas survived if the antibiotic gentamicin was administered in the presence of bacteriophages. None survived without the phages (Microb. Drug Resist., 2006, 12 (3), 164). The bacteriophage ...
Gentamicin in Biological Technology

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

ASHBURN, Va., June 18 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the...

Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States

The antibiotic surgical product may reduce incidence of surgical site infections and reduce post-operative cost and complications DEERFIELD, Ill. and ASHBURN, Va., Aug. 25 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced a licensing agreement with Innocoll Pharmace...

Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge

...e basis of Innocoll Pharmaceuticals' lead product, gentamicin Surgical Implant, a biodegradable leave-behind imp...s US marketing rights to its lead product, CollaRx gentamicin SURGICAL IMPLANT to a division of Baxter Internati...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors

...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...hts, with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain

...treatment of infected diabetic foot ulcers and our gentamicin Surgical Implant for the prevention of surgical si...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...hts, with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...

ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe

... leukemia, and Rapydan(R), a rapid-onset anesthetic patch. EUSA also has several products in late-stage development, notably Collatamp(R) G topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx(R) bupivacaine implant for local post-surgical pain ...

Innocoll Announces Closing of $30 Million Equity Financing Investment

...rmany and South Africa. Innocoll's lead product, gentamicin SURGICAL IMPLANT, is a fully biodegradable, leave-...gned to provide a high localized concentrations of gentamicin at the target tissue. The product is indicated as ...s, with the exception of the U.S., to EUSA Pharma. gentamicin SURGICAL IMPLANT is currently in phase 3 clinical ...

Immunoassay of Theophylline by fluorescence polarisation

... >

Finally, a trial sample was produced which contained the following concentrations of eleven different drugs: gentamicin at 5 g/mL theophylline at 17.8 g/mL tobramycin at 6.5 g/mL quinidine at 2.6 g/mL phenytoin at 12 g/mL ...

High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system

...ll microplates (Cat. #3712) U2OS media: MEM (Gibco Cat. #11095) with 10% heat-inactivated FCS (Gibco Cat. #10082), 10 g/mL gentamicin (Gibco Cat. #15710), 10 mM HEPES (Gibco Cat. #11344), 0.4 mg/mL Zeocin (Gibco Cat. #R250) and 0.4 mg/mL G418 (Gibco Cat. #10131)...
Gentamicin in Biological Definition

Antibiotic

...re are many way to classify antibiotics. One such classification is by chemical structure: Aminoglycosides Amikacin Dibekacin gentamicin Kanamycin Neomycin Netilmicin Paromomycin Sisomycin Streptomycin Tobramycin Beta-lactam ring antibiotics...
Other Tags
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
(Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
(Date:10/20/2014)... 20, 2014 The Advocator Group, ... at the American Foundation for Suicide Prevention’s (AFSP) Out ... is a not-for-profit organization that hosts hundreds of community ... these events are used to help understand and prevent ... personal relationships as well. , The Advocator Group ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 T.E.N., ... relationship-marketing firm, announced today that William H. Murray, ... the 2014 ISE® Luminary Leadership Award winner. Presented ... achievements of an outstanding leader and industry practitioner ... contributions in advancing the information security industry. , ...
(Date:10/20/2014)... Los Angeles, CA (PRWEB) October 20, 2014 ... embodies fitness expertise, nutritional coaching, corporate wellness programming, authorship, ... MS, CPT, is excited to announce the release of ... , After many years of coaching thousands of ... pioneering nutrition tracking app that does not require calorie ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3
(Date:10/16/2014)... 2014 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market ... Wocket™, the Smart Wallet, at the 13 th ... leading global conference on the intersection of technology and ... Anderson , founder and publisher of the Strategic News ...
(Date:10/15/2014)... University Mainz (JGU) as a full member, ensuring ... a significant nationwide standing in the field of ... Gutenberg University Mainz as a full member of ... and international competition for the best minds and ... proud that Mainz University has been recognized as ...
(Date:10/15/2014)... Rosenstiel Award for Distinguished Work in Biomedical Science by ... of genomic instability and its implications for the immune ... to win the Rosenstiel Award; the first, Rod McKinnon, ... the Charles A. Janeway Professor of Pediatrics and Professor ... at the Howard Hughes Medical Institute at Boston Children,s ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
Other Contents